OTC Markets OTCQX - Delayed Quote USD

CSL Limited (CSLLY)

76.91
+0.47
+(0.61%)
As of 11:23:28 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
14,690,000
14,690,000
13,174,000
10,493,100
10,265,300
Cost of Revenue
7,129,000
7,129,000
6,466,000
4,829,600
4,466,700
Gross Profit
7,561,000
7,561,000
6,708,000
5,663,500
5,798,600
Operating Expense
4,797,000
4,797,000
4,606,000
3,347,400
3,208,600
Operating Income
2,764,000
2,764,000
2,102,000
2,316,100
2,590,000
Net Non Operating Interest Income Expense
-437,000
-437,000
-406,000
-160,600
-166,900
Other Income Expense
110,000
110,000
136,000
81,600
44,700
Pretax Income
3,375,000
3,375,000
2,663,000
2,779,600
2,963,100
Tax Provision
661,000
661,000
419,000
524,900
588,100
Net Income Common Stockholders
2,642,000
2,642,000
2,194,000
2,254,700
2,375,000
Basic EPS
2.56
2.73
2.27
2.40
2.61
Diluted EPS
2.54
2.73
2.27
2.40
2.60
Basic Average Shares
965,137.97
966,021.70
964,346.30
937,509.71
909,731.21
Diluted Average Shares
970,507.16
969,541.28
968,653.42
939,458.33
911,708.25
Net Income from Continuing & Discontinued Operation
2,642,000
2,642,000
2,194,000
2,254,700
2,375,000
Normalized Income
2,642,000
2,642,000
2,194,000
2,254,700
2,375,000
Interest Income
39,000
39,000
38,000
17,400
3,900
Interest Expense
420,000
420,000
408,000
142,800
170,800
Net Interest Income
-437,000
-437,000
-406,000
-160,600
-166,900
EBIT
3,795,000
3,795,000
3,071,000
2,922,400
3,133,900
EBITDA
4,733,000
4,733,000
3,902,000
3,464,900
3,629,200
Reconciled Cost of Revenue
7,129,000
7,129,000
6,466,000
4,829,600
4,466,700
Reconciled Depreciation
938,000
938,000
831,000
542,500
495,300
Net Income from Continuing Operation Net Minority Interest
2,642,000
2,642,000
2,194,000
2,254,700
2,375,000
Normalized EBITDA
4,733,000
4,733,000
3,902,000
3,464,900
3,629,200
Tax Rate for Calcs
0
0
0
0
0
6/30/2021 - 12/29/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INRLF Valneva SE
2.8200
0.00%
 
GLPGF Galapagos NV
22.39
0.00%
 
IVBXF Innovent Biologics, Inc.
5.98
0.00%
 
TLPPF Telix Pharmaceuticals Limited
15.90
0.00%
 
BNTC Benitec Biopharma Inc.
13.66
-0.91%
 
APGE Apogee Therapeutics, Inc.
37.55
+5.77%
 
MIRM Mirum Pharmaceuticals, Inc.
39.32
-0.28%
 
ACLX Arcellx, Inc.
65.23
+3.34%
 
SPRO Spero Therapeutics, Inc.
0.7200
-1.63%
 
LIPO Lipella Pharmaceuticals Inc.
2.3500
-1.88%